Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortization of Deferred ChargesAmortizatization of IntangiblesAmortizatization of IntangiblesCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in Acquisitions & DivestmentsChange in CashDepreciation & Amortization (CF)Depreciation & Amortization (CF)Free Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesGains from Sales and DivestituresGains from Sales and DivestituresNet Cash FlowNet Cash FlowNet IncomeNon-cash ItemsNon-cash ItemsOther Working Capital ChangesOther Working Capital ChangesOther financing activitiesOther financing activitiesShare-based CompensationShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Cogent Biosciences (COGT) Change in Account Payables (2017 - 2026)

Cogent Biosciences' Change in Account Payables history spans 10 years, with the latest figure at $4.2 million for Q1 2026.

  • Quarterly Change in Account Payables rose 98.04% to $4.2 million in Q1 2026 from the year-ago period, while the trailing twelve-month figure was -$410000.0 through Mar 2026, up 70.94% year-over-year, with the annual reading at -$2.5 million for FY2025, 284.76% down from the prior year.
  • Change in Account Payables came in at $4.2 million for Q1 2026, up from -$6.5 million in the prior quarter.
  • In the past five years, Change in Account Payables ranged from a high of $6.1 million in Q3 2024 to a low of -$6.6 million in Q2 2024.
  • The 5-year median for Change in Account Payables is $787000.0 (2023), against an average of $603588.2.
  • Year-over-year, Change in Account Payables skyrocketed 671.51% in 2023 and then plummeted 487.29% in 2024.
  • Cogent Biosciences' Change in Account Payables stood at $1.7 million in 2022, then crashed by 55.0% to $787000.0 in 2023, then tumbled by 487.29% to -$3.0 million in 2024, then tumbled by 114.07% to -$6.5 million in 2025, then skyrocketed by 164.98% to $4.2 million in 2026.
  • Per Business Quant, the three most recent readings for COGT's Change in Account Payables are $4.2 million (Q1 2026), -$6.5 million (Q4 2025), and -$596000.0 (Q3 2025).